Table 1.
Clinical and demographic characteristics of participants in the field evaluation of the Panbio™ Ag RDT in Kenya, 2021.
Fig 1.
Flow diagram of enrolment of study participants and distribution by clinical status and test results in the field evaluation of the Panbio™ Ag RDT in Kenya, 2021.
Ag RDT, +ve, +ve, positive; -ve negative; antigen rapid diagnostic test; rRT-PCR–real time reverse transcriptase polymenrase chain reaction.
Fig 2.
Distribution of Cycle threshold (Ct) values for rRT-PCR positive samples by Ag RDT result and by presence/absence of symptoms, Kenya 2021 (n = 551).
Ag RDT, antigen rapid diagnostic test; Ct, cycle threshold; n, number of; rRT-PCR–real time reverse transcriptase polymenrase chain reaction.
Table 2.
The performance of the Panbio™ Ag RDT by clinical status, and Ct value.